ЗинСол 20 мг/5 мл порошок для приготовления суспензии для приема внутрь

Negara: Kirgistan

Bahasa: Rusia

Sumber: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Bahan aktif:

Цинка сульфат

Tersedia dari:

Wilshire Laboratories (Pvt.) Ltd. (Wilshire Laboratories (Pvt.) Ltd.)

Kode ATC:

A12CB01

INN (Nama Internasional):

Zinc sulfate

Dosis:

20 мг/5 мл

Bentuk farmasi:

порошок для приготовления суспензии для приема внутрь

Unit dalam paket:

120 мл

Jenis Resep:

по рецепту

Diproduksi oleh:

Wilshire Laboratories (Pvt.) Ltd. (Пакистан)

Ringkasan produk:

ПЖВЛС: нет

Tanggal Otorisasi:

2019-06-26

Karakteristik produk

n/Zo
I,IH
C
T
PyKIIIIfl
rIO
MEAIIUI'IHC
KO
My
TIPI',IMEHE
HIIIO
TIPEIIAPATA
3I,IHCOJI
Toproooe
Ea3BaHlre
3I,IHCOJI
MexgynapoAHoe
HerIareHToBaHHoe
Ha3BaHrre
Cyns{rat
q}ruKa
JlerapcrrenHafl
QoPua
floporuox
Ars
[p[roroBJIeHI{,
cyc[eH3I4I'I
Ary
rlprleMa
BIIyrpb.
Cocran
KaxAr,re
5
ul
cycueH3l{u
co,qepxar:
Arcmuoruorc
1eulectfiso:
gJleMeHTapsrtfi
quur
(n
rage
qI{HKa
cynrifara
BcnouozametbHbte
Geu4ecm6a:
ac[apTaM,
KCaHTaHoBiUI
KaMeAb,
aHaHagoBafl
TapTpiBuH
Xeltrrft
KpacLITeJIb,
nO4urut
pacTBOp,
TlaTAr^a
AI,IOKcLIA,
Ctxapg3a.
Onncanue
flo.rTff 6enrrfi
flopoluor,
cyxofi,
co
BKycoM
tultulaca,
qBeT
IagMeu.f,eTcc
[p]rf
oToBJreHI,I]I
CyCleH3]II,I
OaprraxorepaneBTuqecnafl
rpyrrrra
Cpe4c,rna,
BJrr{.f,roulue
Ha firruleBapr.rtenrurrft
TpaKT
u
*reta6onragu.
,{pyrrre
M}IHepaJIbHue
Ao6anxu.
I{uHx.
Cynrr[at
qI'IHKa.
Koa
ATX:
A12CB01
(Dapuano.norlrrlecKlre
cnofi
crna
(DapnaxoduH&l/tuKa
Ilnnx
flBJ1f,erc.fi
BaxHbIM
flr.rrareJrbHbrM
Mr{KpogJIeMeHToM,
ueo6xognMblM
Ar.s
pocra
KJreroK
n
ux
auQQepeHIII{aU[u,
pa6orsl
utvtuyuHofi cucreMbl
LI
3neKTlponHToB
B KrrrueqHl4Ke.
I-{uHx
raKxe
BaxeH
AJL
HopMilnbHoro
pocra
I'I
auapeeit
uru
6es
nee.
C
Ae$uqnrorra
qr4HKa
cBr3aH
IIoBbIIIreHHslfi
pucx
xeJly,
uuSerqufi,
uo6o.rHrx
oif(lerron,
BJILIflIoIqIIx
Ha
crpyKrypy
u
pa6ory
xeny
TpaKTia,
a
TaKxe
HapyIIIeHu,
pa6oTbl
uutrlynuoft
cI,IcTeMbI.
Irltrrercrrcs
AocraroqHble
AoKa3areJlbcrBa,
qto6rt
peKoMeH.(oBarb
BcrroMorareJrbHofi
Tepaul,ttl
B
craHAaprHoe
[eqeHI,Ie
uepopaJlruoft
pe
KaK
Arr3eHrepramnofi,
TaK
r{
HeAu3HTeparssofi
ocrpofi
Lvapel,z,.
6urr
upusHaroM
leQuqura
qr,rHxa
u
Anapes.
Moxer
npuBecrr4
x upesuepuofi u
III,IHKA
I,IJII,I
o6ecueqen[s
tl
Mn
.(6anxoporona
ArrpeKropa
IIKII
t4fl
Mf).
4o6anxa,
xerrufi
upu
rIe
Ao6asxu.
HTe3a
6elron,
BOAbI
H
Aerefi
c
bIx
tIIeqHoro
ae
uuHrosofi
uoggofi
coJlblo
LilApef,
MoxeT
K
ero
Ae$I4LILITy.
Hugrag
ocMoJlflpHoctr
I{uurar-O,{
upe4orBpalqaer
ocMoTI{
Bpeueuuoe
rlcrloJlb3oBauue
I{nurat-O,{
Ha
rlporsxeul{Il
10-14
AHef,
KaK
T0lll[['
ryffflffi{ft?T
Tfl?r?fe'r
enrcofli
Ho
rarxe
rlfeflorBfalqaer
Aiul'Henutee
cJreAyr)qlle
2-3
rraecs